The largest database of trusted experimental protocols

Cefepime

Manufactured by bioMérieux
Sourced in France, Sweden

Cefepime is an injectable, broad-spectrum cephalosporin antibiotic used in the treatment of various bacterial infections. It is a fourth-generation cephalosporin that is effective against both Gram-positive and Gram-negative bacteria, including certain antibiotic-resistant strains. Cefepime is indicated for the treatment of serious infections such as pneumonia, complicated urinary tract infections, and skin and soft tissue infections.

Automatically generated - may contain errors

13 protocols using cefepime

1

Characterization and Antibiotic Sensitivity of Bacterial Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oxi/Ferm Pluri Test® (Liofilchem, Italy) was used. The automatic characterization was then carried out using the VITEK®-2 GN identification cards (bioMérieux, Marcy-l’Étoile, France). The motility of the bacterium was tested in Motility Test Agar (Liofilchem, Italy). Antimicrobial sensitivity was determined using E-test in Müller Hinton agar (Pronadisa® Madrid, Spain) using different antibiotics for each strain. For SAICEU11T strain we used cefepime and sulfamethoxazole and trimethoprim (bioMérieux, Marcy-l’Étoile, France); amoxicillin, amoxicillin-clavulanic acid, cefotaxime, cefpirome ciprofloxacin and nalidixic acid (Liofilchem, Italy). For SAICEU22T strain we used piperacillin and piperacillin with tazobactam, cefepime (bioMérieux, Marcy-l’Étoile, France); ceftazidime, imipenem, imipenem with EDTA, amikacin, gentamicin, and ciprofloxacin (Liofilchem, Italy).
Mercury MBC was performed in Müller Hinton agar (Pronadisa®, Madrid, Spain), supplemented with different concentrations of HgCl2: 400, 350, 200, 175, 150, 100, 87.5, 75, 50, 43.75, and 25 μg mL−1. MBC was determined as the lowest concentration of HgCl2 capable of inhibiting > 99.9% of bacterial growth.
+ Open protocol
+ Expand
2

Antibiotic Susceptibility Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility was determined on Mueller–Hinton agar using the standard disk diffusion method, as described by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2017 and also using the Phoenix system. Seventeen antibiotics (bioMérieux, Marcy L’Etoile, France) were tested, namely, amoxicillin (AMX), amoxicillin/clavulanate (AMC), piperacillin/tazobactam (PTZ), cephalothin (CEF), ceftriaxone (CRO), cefepime (CPM), ertapenem (ETP), imipenem (IMP), amikacin (AMK), gentamicin (GEN), ciprofloxacin (CIP), Fosfomycin (FOS), nitrofurantoin (NIT), doxycycline (DCI), trimethoprim/sulfamethoxazole (SXT) and colistin (CS). Sensitivity to imipenem, ertapenem, meropenem (MEM) and colistin was confirmed by the antimicrobial gradient method Etest (bioMérieux, Marcy L’Etoile, France) in collected isolates.
+ Open protocol
+ Expand
3

Automated Characterization of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oxi/Ferm Pluri Test® (Liofilchem, Italy) was used. Next, the automatic characterization was carried out with the VITEK® 2 equipment and with the VITEK®2 GN identification cards (bioMérieux, Marcy-l’Étoile, France). The motility of the bacterium was tested in Motility Test Agar, (Liofilchem, Italy). Antimicrobial sensitivity was determined using E-test in Müller Hinton agar (Pronadisa®, Madrid, Spain) using the following antibiotics: piperacillin and piperacillin with tazobactam, cefepime (bioMérieux, Marcy-l’Étoile, France); ceftazidime, imipenem, imipenem with EDTA, amikacin, gentamicin, and ciprofloxacin (Liofilchem, Italy).
+ Open protocol
+ Expand
4

Antibiotic Susceptibility Profiling of Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibiotic susceptibility profile of the isolates was identified using the standard disk diffusion method on Mueller–Hinton agar (bioMérieux, Marcy l’Etoile, France). Sixteen different antibiotics were tested, including amoxicillin (20 μg), amoxicillin-clavulanic acid (20/10 μg), piperacillin-tazobactam (30/6 μg), cephalotin (30 μg), ceftriaxone (30 μg), cefepime (30 μg), ertapenem (10 μg), imipenem (10 μg), amikacin (30 μg), gentamicin (10 μg), ciprofloxacin (5 μg), Fosfomycin (200 μg), nitrofurantoin (100 μg), tobramycin (10 μg), trimethoprim-sulfamethoxazole (1.25/23.75 μg), and colistin (10 μg) (bioMérieux, Marcy l’Etoile, France). The minimal inhibitory concentration (MIC) of colistin, ertapenem, and imipenem was identified using the microdilution and the E-test methods, respectively. Each strain was considered to be resistant to colistin, ertapenem, and imipenem if their MICs were greater than 2 mg/L, 1 mg/L, and 8 mg/L, respectively. The results were interpreted according to the European Microbial Medical Sensitivity Committee (EUCAST) 2017 (http://www.Sfmicrobiology.Org/Userfiles/Files/Files/CASFM/CASF%20V2_0_MAI2017.PDF, accessed on 25 September 2020).
+ Open protocol
+ Expand
5

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility testing was performed using the broth microdilution susceptibility method (DKYMGN SensititreTM panels, Thermo Fisher Scientific, United States) (International Organization for Standardization [ISO], 2006 ). Antibiotic gradient strips were used to study susceptibility to meropenem/vaborbactam and cefepime (bioMérieux, Marcy-l’Étoile, France) and to imipenem/relebactam, plazomicin, and cefiderocol (Liofilchem, Roseto degli Abruzzi, Italy) in Mueller Hinton agar (bioMérieux, Marcy-l’Étoile, France). EUCAST v12.0 clinical breakpoints and guidelines for Enterobacterales were used for interpretation. An FDA-approved susceptibility breakpoint of ≤ 2 mg/L was used for plazomicin.
+ Open protocol
+ Expand
6

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility testing was performed using the broth microdilution susceptibility method (DKYMGN SensititreTM panels, Thermo Fisher Scientific, Waltham, MA, USA) [36 ]. Antibiotic gradient strips were used to study susceptibility to meropenem/vaborbactam and cefepime (bioMérieux, Marcy-l’Étoile, France), as well as imipenem/relebactam, plazomicin, and cefiderocol (Liofilchem, Roseto degli Abruzzi, Italy) in Mueller Hinton agar (bioMérieux, Marcy-l’Étoile, France). EUCAST v12.0 clinical breakpoints and guidelines for Enterobacterales were used to interpret the data. The Food and Drug Administration-approved susceptibility breakpoint of ≤2 mg/L was used for plazomicin.
+ Open protocol
+ Expand
7

Antibiotic Susceptibility of Soil Microbiome

Check if the same lab product or an alternative is used in the 5 most similar protocols
From the soil extract obtained in saline solution (NaCl 0.45%), it was verified that the density of viable microorganisms was >108 ufc mL−1 (optical density [OD] = 0.5 McFarland). The bacterial extraction was sown in Mueller–Hinton agar (Condalab®, Madrid, Spain), and the minimum inhibitory concentration (MIC) was evaluated by the Kirby–Bauer method, using ε-test antibiotic strips, in triplicate, for the following antibiotics: cefuroxime, cefuroxime axetil, cefoxitin, cefotaxime, ceftazidime, cefepime, ertapenem, imipenem, amikacin, gentamicin, nalidixic acid, ciprofloxacin, tigecycline and trimethoprim/sulfamethoxazole (BioMérieux®, Marcy l’Etoile, France). Plates were then incubated according to the manufacturer’s instructions. For the quantification of the MIC, the most restrictive halo was used as reference.
+ Open protocol
+ Expand
8

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial cultures were grown in the media as indicated in the text to an OD600 of 1.8–2.0. Then, either 200 μl of cultures (high inoculum, corresponding to 4 × 109 CFU/mL) or 100 μl of 1/1,000 dilution of the respective cultures (low inoculum, corresponding to 2 × 106 CFU/mL) were plated on agar plates containing the respective media. MIC Evaluator strips were applied with the following antibiotic concentrations: cefepime, 0.016–256 mg/L (bioMérieux); ciprofloxacin, 0.002–32 mg/L (Oxoid); colistin, 0.016–256 mg/L (bioMérieux); fosfomycin, 0.064–1,024 mg/L (bioMérieux); gentamicin, 0.015–256 mg/L (Oxoid); imipenem, 0.002–32 mg/L (Oxoid); tetracycline, 0.015–256 mg/L (Oxoid). The plates were incubated at 37°C and the MICs were determined by analyzing the growth inhibition zones. The MICs correspond to the lowest concentration of antibiotics that impeded growth.
+ Open protocol
+ Expand
9

Antibiotic Susceptibility Testing of BAL Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BAL fluid from each subject was divided into 2 samples. The first sample was sent to the routine diagnostic laboratory. Antibiotic susceptibilities results were classified as susceptible, intermediate, and resistant by the Phoenix automated microbiology system (BD Diagnostics, le Pont de Claix, France) according to The European Committee on Antimicrobial Susceptibility Testing recommendations. The second BAL sample (10 mL) was sent to our laboratory, where it was subjected to centrifugation (4,000g for 4 min). Once the supernatant was carefully removed, a 1.5-mL aliquot was used to inoculate 2 Mu ¨ller-Hinton and 1 blood agar plates. A set of 9 different E-test strips, including amoxicillin, amoxicillin plus clavulanate, cefotaxime, cefepime, piperacillin, piperacillin-tazobactam, ertapenem, doripenem, and colimycin (BioMe ´rieux, Marcy-L'e ´toile, France), was directly applied to the Mu ¨ller-Hinton agar plates. Vancomycin and cefoxitin E-test strips were applied onto the blood agar plate (Fig. 1). The Mu ¨ller-Hinton agar plates were incubated at 37°C, whereas the blood agar plates were in a 5% CO 2 incubator at 37°C.
+ Open protocol
+ Expand
10

CRE Carbapenemase Screening in Shanghai

Check if the same lab product or an alternative is used in the 5 most similar protocols
From June 2010 to June 2013, 140 CRE isolates were identified in a teaching hospital in Shanghai. In a retrospective review, we screened for several carbapenemase genes (bla KPC , bla IMP , bla VIM , bla OXA-48 , bla NDM , bla NMC , bla IMI , and bla SME ) according to primers used in previous studies (Nordmann et al., 2011; Queenan and Bush, 2007) . Two IMI-positive isolates, the IMI-3-producing Raoultella ornithinolytica RJ46C and the IMI-2-producing Escherichia coli RJ18, were identified and retained for additional study. The minimum inhibitory concentrations (MICs) of amikacin, ciprofloxacin, imipenem, ertapenem, meropenem, ceftriaxone, ceftazidime, cefepime, polymyxin B (bioMérieux, France), and tigecycline (Liofilchem, Italy) were determined by Etests and were interpreted according to Clinical and Laboratory Standards Institute guidelines (M100-S25).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!